Metal-Biomolecule Network Nanoparticles: A New Frontier
Posted by Marketing Team on

The evolution of material science has continuously paved the way for groundbreaking innovations. A recent study, "Assembly and Biological Functions of Metal-Biomolecule Network Nanoparticles Formed by Metal-Phosphonate Coordination," introduces an exciting frontier in hybrid metal-organic materials. The research involves the generation of metal-biomolecule network nanoparticles (MBN NPs) inherent in biomolecules’ natural coordination of metal ions and phosphonate groups. With high biocompatibility, high cargo loading efficiency, and unconventional biological functionalities, this innovation promises new doors in biomedical and material science applications.
Discovery and Methodology
The study describes a one-pot protocol for MBN NPs synthesis when mixing metal ions and phosphonate-containing biomolecules in aqueous solution at room temperature. To show the formation of these nanoparticles, phytic acid (PA), a plant-derived biomolecule, and Fe(II) ions were used as a model system. They found the tunability of the nanoparticles’ properties by changing factors, like metal-to-ligand ratios, biomolecule type and the concentration of the precursors.
Testing the versatility of this method with varying phosphonate-containing biomolecules, DNA, ATP, or proteins upon interaction with different metal ions, Zn(II), Mg(II), Zr(II) or Ce(III). Stable across a range of physiological conditions, these nanoparticles have multiple functionalities, including immune regulation, endosomal escape, and molecular recognition.

A Safer Era for Drug Development
Published in Science Advances, the study by researchers of the University of Melbourne's Caruso Nanoengineering Group highlights the compelling promise of MBN NPs to overcome some of the dogma regarding the toxicity of the carriers traditionally used to develop drugs. This work is led by Melbourne Laureate Professor Frank Caruso and Research Fellows Dr. Wanjun Xu and Dr. Zhixing Lin and highlights how these nanoparticles, comprised solely of non-toxic substances such as iron or calcium and phosphonate biomolecules, are well matched to biological systems. The study further emphasizes the incorporation of diverse cargos—from anticancer drugs to catalytic enzymes—with unprecedented loading efficiencies exceeding 95%.

The versatility of MBN NPs positions them as promising candidates for diverse applications in biomedicine, catalysis, sensing and diagnostics.
Key Equipment and Tools Utilized in the Study
To validate the properties and functionality of the MBN NPs, this research relied heavily on advanced analytical and characterization instruments. Some notable equipment includes:
-
Dynamic Light Scattering (DLS) to study size distribution and stability is essential to understanding how the nanoparticle size changes as it undergoes formation. This gave tunable MBN NPs sizes for a particular application and in the process achieved consistency.
-
Fourier Transform Infrared (FTIR) Spectroscopy was used to confirm the coordination chemistry amongst metal ions and phosphonate groups that are important to the structural integrity of the MBN NPs.
-
Biocompatibility of the NPs was confirmed through Transmission Electron Microscopy (TEM) and Atomic Force Microscopy (AFM) to obtain detailed structural imaging for the shape and surface morphology of the NPs.
-
The evaluation of the efficiency of drug or biomolecule loading in the nanoparticles for biomedical applications, confirming cargo incorporation to the nanoparticles by UV-Vis spectroscopy.
-
The structural organization of the nanoparticle assembly was examined with Small-Angle X-ray Scattering (SAXS), and gain insights into the internal composition of the assembly at equilibrium under physiological conditions.
MSE Supplies: Supporting Advanced Research
The advanced synthesis and characterization of MBN NPs required tools and materials that align with MSE Supplies’ product offerings. Here’s how MSE Supplies can support similar research initiatives:
-
Life Sciences Products: Offers a wide range of life sciences products, providing solutions for centrifugation, incubation, spectroscopy, lab supplies, and biomolecular reagents designed for innovative biomedical applications.
-
High-Purity Inorganic Chemicals and Organic Chemicals: Essential for creating coordination complexes like metal-phosphonate systems. MSE Supplies provides chemicals such as imidazole, ZrCl4, Na2HPO4, NaH2PO4, CeCl3 · 7H2O, and MgCl2 · 6H2O, which were instrumental in the study.
-
Analytical Services: Services such as XRD, FTIR, and fluorescence spectroscopy analysis offered by MSE Supplies ensure the accuracy and reliability of research findings.
-
Bioneer Products: As an authorized distributor of Bioneer, MSE Supplies supports biomolecular research with tools like FAM-labeled DNA and oligonucleotides, as utilized in this study.

Metal biomolecule network nanoparticles herald an important milestone in hybrid material science. Researchers have developed new capabilities in biomedical and environmental applications by harnessing the power of metal-phosphonate coordination. We at MSE Supplies want to enable such groundbreaking research with high-quality materials, state-of-the-art equipment and reliable services.
Ready to accelerate your research? Browse our offerings and learn how our technologies can be your trusted solutions to the next breakthrough.
You can stay informed with the latest product updates, special offers and industry news, just sign up to our email list or follow us on LinkedIn.
Source:
-
Xu, W., Lin, Z., Kim, C., Wang, Z., Wang, T., Cortez-Jugo, C., & Caruso, F. (2024). Assembly and biological functions of metal-biomolecule network nanoparticles formed by metal-phosphonate coordination. Science Advances, 10(50). https://doi.org/10.1126/sciadv.ads9542
-
Nano drug delivery system heralds safer era for drug development. (2024, December 18). Faculty of Engineering and Information Technology. https://eng.unimelb.edu.au/ingenium/health-technologies/nano-drug-delivery-system-heralds-safer-era-for-drug-development


